Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2020 Filed May 16, 2020 00:56 UTC |
Wasman JaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001179110-20-006135 · edgar.xml · derivative · entry 1 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-05-15 F1 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 15, 2020 Filed May 16, 2020 00:55 UTC |
Katkin KeithDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001179110-20-006134 · edgar.xml · derivative · entry 1 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-05-15 F1 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 15, 2020 Filed May 16, 2020 00:53 UTC |
Kotzin Brian L.Director
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001179110-20-006133 · edgar.xml · derivative · entry 1 Kotzin Brian L. · CIK 0001715332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-05-15 F1 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 15, 2020 Filed May 16, 2020 00:53 UTC |
LAPOINTE ANTHONY GREGGDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001179110-20-006132 · edgar.xml · derivative · entry 1 LAPOINTE ANTHONY GREGG · CIK 0001331860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-05-15 F1 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 15, 2020 Filed May 16, 2020 00:52 UTC |
Goodwin Bradford SDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001179110-20-006131 · edgar.xml · derivative · entry 1 Goodwin Bradford S · CIK 0001293633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-05-15 F1 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 15, 2020 Filed May 16, 2020 00:51 UTC |
MOOS WALTER HDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001179110-20-006130 · edgar.xml · derivative · entry 1 MOOS WALTER H · CIK 0001190272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-05-15 F1 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 15, 2020 Filed May 16, 2020 00:50 UTC |
LYONS GARY ADirector
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001179110-20-006129 · edgar.xml · derivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-05-15 F1 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 14, 2020 Filed May 16, 2020 00:57 UTC |
Cabatuan NelsonVP,Finance & Princ.Acctg. Off.
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001179110-20-006136 · edgar.xml · derivative · entry 1 Cabatuan Nelson · CIK 0001725908 · VP,Finance & Princ.Acctg. Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: Fifty per cent (50%) of the shares subject to the option shall vest one year from the date of grant and fifty per cent (50%) of the shares subject to the option shall vest shall vest two years from the date of grant, subject to the reporting person's continuous service to the issuer through each such period. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 23:31 UTC |
Cabatuan NelsonVP,Finance & Princ.Acctg. Off.
|
GrantStock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001179110-20-001351 · edgar.xml · derivative · entry 1 Cabatuan Nelson · CIK 0001725908 · VP,Finance & Princ.Acctg. Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2030-02-06 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2020, subject to the reporting person's continuous service to the issuer through each such period. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 23:30 UTC |
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001179110-20-001350 · edgar.xml · derivative · entry 1 VANCE DOLLY · CIK 0001237676 · EVP Corp. Affairs, G.C., Sect. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2030-02-06 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2020, subject to the reporting person's continuous service to the issuer through each such period. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 23:16 UTC |
Schorno Dean LEVP &Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001179110-20-001349 · edgar.xml · derivative · entry 1 Schorno Dean L · CIK 0001509688 · EVP &Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2030-02-06 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2020, subject to the reporting person's continuous service to the issuer through each such period. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 23:12 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantStock Option (right to buy) · Derivative | 650,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001179110-20-001348 · edgar.xml · derivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,000 Underlying: Common Stock · 650,000 shares Expires 2030-02-06 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2020, subject to the reporting person's continuous service to the issuer through each such period. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 01:11 UTC |
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-19-011940 · edgar.xml · derivative · entry 1 VANCE DOLLY · CIK 0001237676 · EVP Corp. Affairs, G.C., Sect. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: The reporting person was granted a performance based option to purchase 75,000 shares of common stock on January 24, 2018. Thus,the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 01:23 UTC |
Schorno Dean LEVP &Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 83,750 | $0.00 Strike: $3.44 | $0.00 |
DisclosureSEC source: 0001179110-19-011948 · edgar.xml · derivative · entry 1 Schorno Dean L · CIK 0001509688 · EVP &Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,750 Underlying: Common Stock · 83,750 shares Expires 2028-06-04 F1 · derivative.exercise_price: The reporting person was granted a performance based option to purchase 83,750 shares of common stock on June 4, 2018. Thus,the exercise price of this option is $3.44 (the closing price of the issuer's common stock on Nasdaq the day of the grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met. F1 · derivative.exercise_date: The reporting person was granted a performance based option to purchase 83,750 shares of common stock on June 4, 2018. Thus,the exercise price of this option is $3.44 (the closing price of the issuer's common stock on Nasdaq the day of the grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 01:18 UTC |
Masuda EstebanSr. VP Research
|
SaleEmployee Stock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-19-011944 · edgar.xml · derivative · entry 1 Masuda Esteban · CIK 0001686849 · Sr. VP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2028-01-24 F1 · derivative.exercise_price: The reporting person was granted a performance based option to purchase 62,500 shares of common stock on January 24, 2018. Thus, the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met.. F1 · derivative.exercise_date: The reporting person was granted a performance based option to purchase 62,500 shares of common stock on January 24, 2018. Thus, the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met.. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 01:20 UTC |
Lasaga JosephSr.VP Bus.Dev.Alliance Mgmt.
|
GrantEmployee Stock Option (right to buy) · Derivative | 43,750 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-19-011946 · edgar.xml · derivative · entry 1 Lasaga Joseph · CIK 0001686916 · Sr.VP Bus.Dev.Alliance Mgmt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 Underlying: Common Stock · 43,750 shares Expires 2028-01-24 F1 · derivative.exercise_price: The reporting person was granted a performance based option to purchase 43,750 shares of common stock on January 24, 2018. Thus, the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met. F1 · derivative.exercise_date: The reporting person was granted a performance based option to purchase 43,750 shares of common stock on January 24, 2018. Thus, the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 01:15 UTC |
Mayer Eldon C. IIIEVP & Chief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-19-011942 · edgar.xml · derivative · entry 1 Mayer Eldon C. III · CIK 0001686952 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-01-24 F1 · derivative.exercise_price: The reporting person was granted a performance based option to purchase 75,000 shares of common stock on January 24, 2018. Thus,the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met. F1 · derivative.exercise_date: The reporting person was granted a performance based option to purchase 75,000 shares of common stock on January 24, 2018. Thus,the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 01:06 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantEmployee Stock Option (right to buy) · Derivative | 237,500 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-19-011938 · edgar.xml · derivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,500 Underlying: Common Stock · 237,500 shares Expires 2028-01-24 F1 · derivative.exercise_price: The reporting person was granted a performance based option to purchase 237,500 shares of common stock on January 24, 2018. Thus,the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met. F1 · derivative.exercise_date: The reporting person was granted a performance based option to purchase 237,500 shares of common stock on January 24, 2018. Thus,the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 01:05 UTC |
Dummer WolfgangEVP & CMO
|
GrantEmployee Stock Option (right to buy) · Derivative | 220,000 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001179110-19-011937 · edgar.xml · derivative · entry 1 Dummer Wolfgang · CIK 0001749991 · EVP & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2029-11-18 F1 · derivative.exercise_date: Common Stock subject to the Option shall vest over a four-year term, with one-fourth of the shares subject to the Option vesting on November 18, 2020, and 1/48th of the shares subject to the Option vesting monthly thereafter, subject to the Continuous Service (as defined in the Plan) to the Company through each vesting date. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:19 UTC |
Kotzin Brian L.Director
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001179110-19-006701 · edgar.xml · derivative · entry 1 Kotzin Brian L. · CIK 0001715332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2029-05-23 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:23 UTC |
Katkin KeithDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001179110-19-006703 · edgar.xml · derivative · entry 1 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2029-05-23 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:21 UTC |
Goodwin Bradford SDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001179110-19-006702 · edgar.xml · derivative · entry 1 Goodwin Bradford S · CIK 0001293633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2029-05-23 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:18 UTC |
Wasman JaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,750 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001179110-19-006700 · edgar.xml · derivative · entry 1 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2029-05-23 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year) from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:17 UTC |
LAPOINTE ANTHONY GREGGDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001179110-19-006699 · edgar.xml · derivative · entry 1 LAPOINTE ANTHONY GREGG · CIK 0001331860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2029-05-23 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:15 UTC |
LYONS GARY ADirector
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001179110-19-006698 · edgar.xml · derivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2029-05-23 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:08 UTC |
MOOS WALTER HDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001179110-19-006694 · edgar.xml · derivative · entry 1 MOOS WALTER H · CIK 0001190272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2029-05-23 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 22, 2019 Filed May 24, 2019 00:21 UTC |
Schorno Dean LEVP &Chief Financial Officer
|
PurchaseCommon Stock | 3,274 | $2.13 | $6,971.00 |
DisclosureSEC source: 0001179110-19-006608 · edgar.xml · nonDerivative · entry 2 Schorno Dean L · CIK 0001509688 · EVP &Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| May 22, 2019 Filed May 24, 2019 00:21 UTC |
Schorno Dean LEVP &Chief Financial Officer
|
PurchaseCommon Stock | 46,726 | $2.13 | $99,573.11 |
DisclosureSEC source: 0001179110-19-006608 · edgar.xml · nonDerivative · entry 1 Schorno Dean L · CIK 0001509688 · EVP &Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,726 Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 22:36 UTC |
Wasman JaneDirector
|
GrantStock Option ( Right to Buy) · Derivative | 80,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001179110-19-004740 · edgar.xml · derivative · entry 1 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2029-04-01 F1 · derivative.exercise_date: The Option shall vest in equal monthly installments over the shorter of three years from the date of grant or the period beginning on the date the director is appointed to the Board and ending on the date of the annual meeting at which the director is first considered for election by the stockholders, provided that the non-employee director continues to provide services. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 23:22 UTC |
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-19-004207 · edgar.xml · derivative · entry 1 VANCE DOLLY · CIK 0001237676 · EVP Corp. Affairs, G.C., Sect. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: On January 24, 2018, the reporting person was granted a performance based option to purchase 75,000 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 23:19 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-19-004206 · edgar.xml · derivative · entry 1 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: On January 24, 2018, the reporting person was granted a performance based option to purchase 75,000 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 23:28 UTC |
Schorno Dean LEVP &Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 83,750 | $0.00 Strike: $3.44 | $0.00 |
DisclosureSEC source: 0001179110-19-004212 · edgar.xml · derivative · entry 1 Schorno Dean L · CIK 0001509688 · EVP &Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,750 Underlying: Common Stock · 83,750 shares Expires 2028-06-04 F1 · derivative.exercise_date: On June 4, 2018, the reporting person was granted a performance based option to purchase 83,750 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 23:26 UTC |
Markel StacyEVP Human Resources
|
GrantEmployee Stock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001179110-19-004211 · edgar.xml · derivative · entry 1 Markel Stacy · CIK 0001734780 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2028-03-21 F1 · derivative.exercise_date: On March 21, 2018, the reporting person was granted a performance based option to purchase 62,500 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 23:25 UTC |
Lasaga JosephSr.VP Bus.Dev.Alliance Mgmt.
|
GrantEmployee Stock Option (right to buy) · Derivative | 43,750 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-19-004210 · edgar.xml · derivative · entry 1 Lasaga Joseph · CIK 0001686916 · Sr.VP Bus.Dev.Alliance Mgmt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 Underlying: Common Stock · 43,750 shares Expires 2028-01-24 F1 · derivative.exercise_date: On January 24, 2018, the reporting person was granted a performance based option to purchase 43,750 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 23:23 UTC |
Mayer Eldon C. IIIEVP & Chief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-19-004208 · edgar.xml · derivative · entry 1 Mayer Eldon C. III · CIK 0001686952 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: On January 24, 2018, the reporting person was granted a performance based option to purchase 75,000 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 23:24 UTC |
Masuda EstebanSr. VP Research
|
GrantEmployee Stock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-19-004209 · edgar.xml · derivative · entry 1 Masuda Esteban · CIK 0001686849 · Sr. VP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2028-01-24 F1 · derivative.exercise_date: On January 24, 2018, the reporting person was granted a performance based option to purchase 62,500 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 23:17 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantEmployee Stock Option (right to buy) · Derivative | 237,500 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-19-004205 · edgar.xml · derivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,500 Underlying: Common Stock · 237,500 shares Expires 2028-01-24 F1 · derivative.exercise_date: On January 24, 2018, the reporting person was granted a performance based option to purchase 237,500 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 23:55 UTC |
Cabatuan NelsonPrincipal Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000940 · edgar.xml · derivative · entry 1 Cabatuan Nelson · CIK 0001725908 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 23:53 UTC |
Lasaga JosephSr.VP Bus.Dev.Alliance Mgmt.
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000939 · edgar.xml · derivative · entry 1 Lasaga Joseph · CIK 0001686916 · Sr.VP Bus.Dev.Alliance Mgmt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 23:51 UTC |
Masuda EstebanSr. VP Research
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000938 · edgar.xml · derivative · entry 1 Masuda Esteban · CIK 0001686849 · Sr. VP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 23:41 UTC |
Markel StacyEVP Human Resources
|
GrantEmployee Stock Option (right to buy) · Derivative | 137,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000936 · edgar.xml · derivative · entry 1 Markel Stacy · CIK 0001734780 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,500 Underlying: Common Stock · 137,500 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 23:36 UTC |
Mayer Eldon C. IIIEVP & Chief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000935 · edgar.xml · derivative · entry 1 Mayer Eldon C. III · CIK 0001686952 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 23:32 UTC |
Schorno Dean LEVP &Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 162,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000934 · edgar.xml · derivative · entry 1 Schorno Dean L · CIK 0001509688 · EVP &Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,500 Underlying: Common Stock · 162,500 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 23:23 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 162,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000933 · edgar.xml · derivative · entry 1 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,500 Underlying: Common Stock · 162,500 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 23:20 UTC |
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.
|
GrantEmployee Stock Option (right to buy) · Derivative | 162,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000932 · edgar.xml · derivative · entry 1 VANCE DOLLY · CIK 0001237676 · EVP Corp. Affairs, G.C., Sect. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,500 Underlying: Common Stock · 162,500 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 23:17 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantEmployee Stock Option (right to buy) · Derivative | 600,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000931 · edgar.xml · derivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2029-01-23 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 22:46 UTC |
Cabatuan NelsonPrincipal Accounting Officer
|
SaleCommon Stock | 10,000 | $3.12 | $31,200.00 |
DisclosureSEC source: 0001179110-18-012211 · edgar.xml · nonDerivative · entry 1 Cabatuan Nelson · CIK 0001725908 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 5, 2018. F2 · shares: Includes Reporting Person's purchases of 5,000 shares on December 29, 2017 and 5,000 shares on June 26, 2018 under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:26 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-18-011567 · edgar.xml · derivative · entry 6 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 37,500 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares vest over four (4) years from January 1, 2017. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:26 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
Exercise / conversionEmploye Stock Option (right to buy) · Derivative | 115,500 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001179110-18-011567 · edgar.xml · derivative · entry 5 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,000 Underlying: Common Stock · 115,500 shares Expires 2026-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One fourth (1/4th) of the option vests one (1) year from March 7, 2016 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:26 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
SaleCommon Stock | 37,500 | $3.50 | $131,250.00 |
DisclosureSEC source: 0001179110-18-011567 · edgar.xml · nonDerivative · entry 4 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.